Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Miglustat PK and Tolerability in Juvenile GM2 Gangliosidosis
NCT00418847Phase 2Completed
- Sponsor
- SickKids
- Start
- Jul 2004
- Primary completion
- Apr 2009
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of miglustat in GM2 gangliosidosis, sponsored by SickKids. Started Jul 2004; status: completed.
02
Drugs
miglustat
03
Conditions
GM2 gangliosidosis
Beyond the preview
Go deeper on NCT00418847.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00418847.